145 related articles for article (PubMed ID: 17643093)
1. EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.
Wei EX; Anga AA; Martin SS; Jackson JG; Nordberg ML; Herrera GA; Turbat-Herrera EA
Mod Pathol; 2007 Sep; 20(9):905-13. PubMed ID: 17643093
[TBL] [Abstract][Full Text] [Related]
2. Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer.
Simone G; Mangia A; Malfettone A; Rubini V; Siciliano M; Di Benedetto A; Terrenato I; Novelli F; Mottolese M
J Exp Clin Cancer Res; 2010 Sep; 29(1):125. PubMed ID: 20843314
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients.
Schenk T; Ackermann J; Brunner C; Schenk P; Zojer N; Roka S; Drach J
Chest; 1997 Jun; 111(6):1691-6. PubMed ID: 9187195
[TBL] [Abstract][Full Text] [Related]
4. A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.
Liu YZ; Wang Z; Fang LL; Li L; Cao J; Xu X; Han YL; Cai Y; Wang LX; Wang MR
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1541-9. PubMed ID: 22538453
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
[TBL] [Abstract][Full Text] [Related]
6. [Predictive EGFR gene analyses in cytology].
Bubendorf L; Savic S
Pathologe; 2009 Dec; 30 Suppl 2():136-9. PubMed ID: 19859710
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.
Savic S; Tapia C; Grilli B; Rufle A; Bihl MP; de Vito Barascud A; Herzog M; Terracciano L; Baty F; Bubendorf L
Br J Cancer; 2008 Jan; 98(1):154-60. PubMed ID: 18087280
[TBL] [Abstract][Full Text] [Related]
8. Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.
Gaber R; Watermann I; Kugler C; Reinmuth N; Huber RM; Schnabel PA; Vollmer E; Reck M; Goldmann T
Diagn Pathol; 2014 Sep; 9():165. PubMed ID: 25227424
[TBL] [Abstract][Full Text] [Related]
9. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
[TBL] [Abstract][Full Text] [Related]
10. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens.
Sokolova IA; Bubendorf L; O'Hare A; Legator MS; Jacobson KK; Grilli B S B; Dalquen P; Halling KC; Tamm M; Seelig SA; Morrison LE
Cancer; 2002 Oct; 96(5):306-15. PubMed ID: 12378599
[TBL] [Abstract][Full Text] [Related]
11. Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients.
Ludovini V; Flacco A; Bianconi F; Ragusa M; Vannucci J; Bellezza G; Chiari R; Minotti V; Pistola L; Tofanetti FR; Siggillino A; Baldelli E; Sidoni A; Daddi N; Puma F; Varella-Garcia M; Crinò L
Cancer Chemother Pharmacol; 2013 Mar; 71(3):671-80. PubMed ID: 23314677
[TBL] [Abstract][Full Text] [Related]
12. Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.
Daniele L; Macrì L; Schena M; Dongiovanni D; Bonello L; Armando E; Ciuffreda L; Bertetto O; Bussolati G; Sapino A
Mol Cancer Ther; 2007 Apr; 6(4):1223-9. PubMed ID: 17406029
[TBL] [Abstract][Full Text] [Related]
13. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
Fukuoka M; Wu YL; Thongprasert S; Sunpaweravong P; Leong SS; Sriuranpong V; Chao TY; Nakagawa K; Chu DT; Saijo N; Duffield EL; Rukazenkov Y; Speake G; Jiang H; Armour AA; To KF; Yang JC; Mok TS
J Clin Oncol; 2011 Jul; 29(21):2866-74. PubMed ID: 21670455
[TBL] [Abstract][Full Text] [Related]
14. A comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.
Wang X; Wang G; Hao Y; Xu Y; Zhang L
Int J Clin Exp Pathol; 2014; 7(7):4310-6. PubMed ID: 25120814
[TBL] [Abstract][Full Text] [Related]
15. Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.
Hirsch FR; Herbst RS; Olsen C; Chansky K; Crowley J; Kelly K; Franklin WA; Bunn PA; Varella-Garcia M; Gandara DR
J Clin Oncol; 2008 Jul; 26(20):3351-7. PubMed ID: 18612151
[TBL] [Abstract][Full Text] [Related]
16. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.
Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A
Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
Pinter F; Papay J; Almasi A; Sapi Z; Szabo E; Kanya M; Tamasi A; Jori B; Varkondi E; Moldvay J; Szondy K; Keri G; Dominici M; Conte P; Eckhardt S; Kopper L; Schwab R; Petak I
J Mol Diagn; 2008 Mar; 10(2):160-8. PubMed ID: 18258923
[TBL] [Abstract][Full Text] [Related]
18. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.
Halling KC; Rickman OB; Kipp BR; Harwood AR; Doerr CH; Jett JR
Chest; 2006 Sep; 130(3):694-701. PubMed ID: 16963665
[TBL] [Abstract][Full Text] [Related]
19. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.
Sholl LM; John Iafrate A; Chou YP; Wu MT; Goan YG; Su L; Huang YT; Christiani DC; Chirieac LR
Mod Pathol; 2007 Oct; 20(10):1028-35. PubMed ID: 17673923
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer.
Jeon YK; Sung SW; Chung JH; Park WS; Seo JW; Kim CW; Chung DH
Lung Cancer; 2006 Dec; 54(3):387-98. PubMed ID: 17011067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
